First Time Loading...

Genoway SA
PAR:ALGEN

Watchlist Manager
Genoway SA Logo
Genoway SA
PAR:ALGEN
Watchlist
Price: 4.3 EUR 1.18% Market Closed
Updated: May 17, 2024
Section:
 

Relative Value

The Relative Value of one ALGEN stock under the Base Case scenario is 6.98 EUR. Compared to the current market price of 4.3 EUR, Genoway SA is Undervalued by 38%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALGEN Relative Value
Base Case
6.98 EUR
Undervaluation 38%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2
P/S
P/S
Price to Sales
2
vs History
38
vs Industry
80
Median 3Y
2.1
Median 5Y
1.9
Industry
8.2
Forward
1.8
More Details
23.7
P/E
P/E
Price to Earnings
23.7
vs History
20
vs Industry
7
Median 3Y
22.1
Median 5Y
-9.1
Industry
26.1
Forward
20.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
9
Median 3Y
-44.9
Median 5Y
-5.9
Industry
24.8
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
2
Median 3Y
-10.8
Median 5Y
-4.4
Industry
23.4
More Details
2.3
P/B
P/B
Price to Book Value
2.3
vs History
23
vs Industry
40
Median 3Y
2.2
Median 5Y
2.2
Industry
2.6
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
41
vs Industry
69
Median 3Y
2.2
Median 5Y
2.1
Industry
7.4
Forward
2
More Details
2.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
2.3
vs History
49
vs Industry
70
Median 3Y
2.4
Median 5Y
2.2
Industry
9.1
More Details
9.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
9.1
vs History
77
vs Industry
10
Median 3Y
11.3
Median 5Y
20.1
Industry
4.6
Forward
9.7
More Details
23.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.9
vs History
20
vs Industry
6
Median 3Y
22.3
Median 5Y
-19.1
Industry
4.4
Forward
19
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
9
Median 3Y
-49.1
Median 5Y
-7.9
Industry
6.4
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
-7
Median 5Y
-4.6
Industry
3.8
More Details
1.5
EV/IC
EV/IC
Enterprise Value to IC
1.5
vs History
12
vs Industry
54
Median 3Y
1.4
Median 5Y
1.4
Industry
4.9
More Details

Multiples Across Competitors

ALGEN Competitors Multiples
Genoway SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Genoway SA
PAR:ALGEN
37.8m EUR 2 23.7 9.1 23.9
US
Abbvie Inc
NYSE:ABBV
293.4B USD 5.4 60.9 13.2 20.1
US
Amgen Inc
NASDAQ:AMGN
168.1B USD 5.7 44.7 18.8 31
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.5B USD 11.6 31.6 25.6 26.8
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
107.8B USD 8.2 28 22.6 25.1
AU
CSL Ltd
ASX:CSL
135.3B AUD 6.4 36.6 22.1 27.4
US
Gilead Sciences Inc
NASDAQ:GILD
84.3B USD 3.1 174.2 7 9.2
US
Moderna Inc
NASDAQ:MRNA
51.1B USD 9.9 -8.6 -9.5 -8.4
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
33.4B USD 3.5 28.6 14.5 18.2
KR
Celltrion Inc
KRX:068270
39.7T KRW 18.2 74.1 45.3 62.4

See Also

Summary
ALGEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALGEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALGEN stock valuation using valuation multiples.
Wall Street Estimates
ALGEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALGEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.